Caryn Fenner and Petro Terblanche outline Afrigen's clinical trial plans, local partnerships, and vaccine pipeline.
Petro Terblanche
Advertisement
CEO of Afrigen.
Articles by Petro Terblanche
Caryn Fenner and Petro Terblanche explain how CEPI’s $6.2 million grant will advance Afrigen’s mRNA vaccine for Rift Valley fever through preclinical and Phase I trials in Africa.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Phage and Antibiotic Combination Therapy for Biofilm-Associated Bacterial Infections
2
Maldives Validated by WHO as First Country to Achieve Triple EMTCT of HIV, Syphilis, and Hepatitis B
3
WHO Calls for Global Action on Growing AMR
4
Streamlining IV-to-Oral Transitions in Pneumonia Care: Duration, Tailoring, and Post-Discharge Considerations
5
